15. Pfizer Inc., working collaboratively with the European School of Oncology (ESO) and within the scope of the Advanced Breast Cancer Third International Consensus Conference (ABC3), commissioned The Global Status of Advanced/Metastatic Breast Cancer Decade Report

Advancing mBC Patient Care

The health information contained herein is provided for educational purposes only and is not intended to replace discussions with a health care provider. All decisions regarding patient care must be made with a health care provider, considering the unique characteristics of the patient.